BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation. 1994;58:155-170. [PMID: 7518974 DOI: 10.1097/00007890-199405820-00006] [Cited by in Crossref: 141] [Cited by in F6Publishing: 96] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Miller LW. Cyclosporine-Associated Neurotoxicity: The Need for a Better Guide for Immunosuppressive Therapy. Circulation 1996;94:1209-11. [DOI: 10.1161/01.cir.94.6.1209] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
2 Mangino JE, Kotadia B, Mangino MJ. Characterization of hypothermic intestinal ischemia-reperfusion injury in dogs. Effects of glycine. Transplantation 1996;62:173-8. [PMID: 8755812 DOI: 10.1097/00007890-199607270-00005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 0.9] [Reference Citation Analysis]
3 Bush WW. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. AACN Clin Issues 1999;10:253-69; quiz 304-6. [PMID: 10578712 DOI: 10.1097/00044067-199905000-00011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sakamoto Y, Makuuchi M, Harihara Y, Imamura H, Sato H. Higher intracerebral concentration of tacrolimus after intermittent than continuous administration to rats. Liver Transpl 2001;7:1071-6. [PMID: 11753909 DOI: 10.1053/jlts.2001.28964] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Ingu A, Komatsu K, Ichimiya S, Sato N, Hirayama Y, Morikawa M, Abe T. Effects of Inhaled FK 506 on the Suppression of Acute Rejection After Lung Transplantation: Use of a Rat Orthotopic Lung Transplantation Model. The Journal of Heart and Lung Transplantation 2005;24:538-43. [DOI: 10.1016/j.healun.2003.12.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
6 Ellis JS, Seymour RA, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol. 2004;31:126-131. [PMID: 15016038 DOI: 10.1111/j.0303-6979.2004.00459.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
7 Trull A. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation. Liver Transplantation 2002;8:224-32. [DOI: 10.1053/jlts.2002.31347] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
8 Steg RE, Wszolek ZK. Electroencephalographic abnormalities in liver transplant recipients: practical considerations and review. J Clin Neurophysiol 1996;13:60-8. [PMID: 8988286 DOI: 10.1097/00004691-199601000-00006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
9 Ahern GP, Junankar PR, Dulhunty AF. Ryanodine receptors from rabbit skeletal muscle are reversibly activated by rapamycin. Neuroscience Letters 1997;225:81-4. [DOI: 10.1016/s0304-3940(97)00193-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
10 Balderramo D, Prieto J, Cárdenas A, Navasa M. Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantation: Risk factors for early calcineurin inhibitor-induced neurotoxicity. Transplant International 2011;24:812-9. [DOI: 10.1111/j.1432-2277.2011.01280.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
11 Steiner JP, Connolly MA, Valentine HL, Hamilton GS, Dawson TM, Hester L, Snyder SH. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat Med 1997;3:421-8. [DOI: 10.1038/nm0497-421] [Cited by in Crossref: 253] [Cited by in F6Publishing: 238] [Article Influence: 10.5] [Reference Citation Analysis]
12 Lagman C, Nagasawa DT, Azzam D, Sheppard JP, Chen CHJ, Ong V, Nguyen T, Prashant GN, Niu T, Tucker AM, Kim W, Kaldas FM, Pouratian N, Busuttil RW, Yang I. Survival Outcomes After Intracranial Hemorrhage in Liver Disease. Oper Neurosurg (Hagerstown) 2019;16:138-46. [PMID: 29767779 DOI: 10.1093/ons/opy096] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wszolek ZK, Steg RE. Seizures after liver transplantation. Liver Transpl 1995;1:334-9. [DOI: 10.1002/lt.500010512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
14 Veroux P, Veroux M, Puliatti C, Morale W, Cappello D, Valvo M, Macarone M. Tacrolimus-induced neurotoxicity in kidney transplant recipients. Transplantation Proceedings 2002;34:3188-90. [DOI: 10.1016/s0041-1345(02)03606-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kanwal F, Chen D, Ting L, Gornbein J, Saab S, Durazo F, Yersiz H, Farmer D, Ghobrial RM, Busuttil RW. A model to predict the development of mental status changes of unclear cause after liver transplantation. Liver Transpl. 2003;9:1312-1319. [PMID: 14625832 DOI: 10.1016/j.lts.2003.09.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
16 Sierra-hidalgo F, Martínez-salio A, Moreno-garcía S, de Pablo-fernández E, Correas-callero E, Ruiz-morales J. Akinetic Mutism Induced by Tacrolimus. Clinical Neuropharmacology 2009;32:293-4. [DOI: 10.1097/wnf.0b013e3181a77fab] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
17 Mueller AR, Platz KP, Heckert C, Häusler M, Radke C, Neuhaus P. L-arginine application improves mucosal structure after small bowel transplantation. Transplant Proc. 1998;30:2336-2338. [PMID: 9723495 DOI: 10.1016/S0041-1345(98)00644-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
18 Wiklund U, Hörnsten R, Olofsson B, Suhr OB. Cardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathy. Autonomic Neuroscience 2010;156:124-30. [DOI: 10.1016/j.autneu.2010.04.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
19 Amodio P, Biancardi A, Montagnese S, Angeli P, Iannizzi P, Cillo U, D’Amico D, Gatta A. Neurological complications after orthotopic liver transplantation. Dig Liver Dis. 2007;39:740-747. [PMID: 17611177 DOI: 10.1016/j.dld.2007.05.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
20 McDiarmid SV. Current status of liver transplantation in children. Pediatr Clin North Am. 2003;50:1335-1374. [PMID: 14710783 DOI: 10.1016/S0031-3955(03)00150-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
21 Souto-Rodríguez R, Molina-Pérez E, Castroagudín JF, Fernández Pérez A, Otero-Antón E, Tomé Martínez de Rituerto S, Martínez-Castro J, Varo-Pérez E. Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol. Transplant Proc 2014;46:3117-20. [PMID: 25420839 DOI: 10.1016/j.transproceed.2014.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Gavrilovici C, Miron I, Voroneanu L, Bădărau S, Stârcea M. Posterior reversible encephalopathy syndrome in children with kidney disease. Int Urol Nephrol 2017;49:1793-800. [DOI: 10.1007/s11255-017-1684-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bilbao I, Dopazo C, Castells L, Lazaro J, Caralt M, Sapisochin G, Charco R. Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity. Transplant Proc. 2014;46:3104-3107. [PMID: 25420835 DOI: 10.1016/j.transproceed.2014.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
24 Pustavoitau A, Bhardwaj A, Stevens R. Analytic Review: Neurological Complications of Transplantation. J Intensive Care Med 2011;26:209-22. [DOI: 10.1177/0885066610389549] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
25 Hausen B, Morris RE. REVIEW OF IMMUNOSUPPRESSION FOR LUNG TRANSPLANTATION. Clinics in Chest Medicine 1997;18:353-66. [DOI: 10.1016/s0272-5231(05)70384-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Testa G, Klintmalm GB. CYCLOSPORINE AND TACROLIMUS. Clinics in Liver Disease 1997;1:417-37. [DOI: 10.1016/s1089-3261(05)70278-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Osunkwo I, Bessmertny O, Harrison L, Cheung YK, Van de Ven C, del Toro G, Garvin J, George D, Bradley MB, Wolownik K, Wischhover C, Levy J, Skerrett D, Cairo MS. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2004;10:246-58. [PMID: 15077223 DOI: 10.1016/j.bbmt.2003.11.005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 4.9] [Reference Citation Analysis]
28 Wang Y, Qin Q, Chen J, Kuang X, Xia J, Xie B, Wang F, Liang H, Qi Z. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. Transplant Immunology 2009;22:5-11. [DOI: 10.1016/j.trim.2009.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
29 Yilmaz S, Gokben S, Arikan C, Calli C, Serdaroglu G. Reversibility of Cytotoxic Edema in Tacrolimus Leukoencephalopathy. Pediatric Neurology 2010;43:359-62. [DOI: 10.1016/j.pediatrneurol.2010.05.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
30 Pollard S, Lodge J. Optimization of cyclosporine therapy in liver transplantation. Transplantation Proceedings 1998;30:1816-8. [DOI: 10.1016/s0041-1345(98)00443-6] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
31 Kimikawa M, Kamoya K, Toma H, Teraoka S. Effective oral administration of tacrolimus in renal transplant recipients: Effective oral administration of tacrolimus. Clin Transplantation 2001;15:324-9. [DOI: 10.1034/j.1399-0012.2001.150504.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
32 Davis B, Hilgart D, Erickson S, Labroo P, Burton J, Sant H, Shea J, Gale B, Agarwal J. Local FK506 delivery at the direct nerve repair site improves nerve regeneration. Muscle Nerve 2019;60:613-20. [PMID: 31397908 DOI: 10.1002/mus.26656] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
33 Murakami S, Bacha E, Mazmanian G, Détruit H, Chapelier A, Dartevelle P, Hervé P. Effects of Various Timings and Concentrations of Inhaled Nitric Oxide in Lung Ischemia–Reperfusion. Am J Respir Crit Care Med 1997;156:454-8. [DOI: 10.1164/ajrccm.156.2.9608007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
34 Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transplant Int 2000;13:313-26. [DOI: 10.1111/j.1432-2277.2000.tb01004.x] [Cited by in Crossref: 358] [Cited by in F6Publishing: 176] [Article Influence: 17.0] [Reference Citation Analysis]
35 Szabó G, Bátkai S, Bährle S, Dengler TJ, Vahl CF, Zimmermann R, Hagl S. Effects of Nitric Oxide Synthesis on Reperfusion Injury and Catecholamine Responsiveness in a Heterotopic Rat Heart-Transplantation Model: . Journal of Cardiovascular Pharmacology 1998;31:221-30. [DOI: 10.1097/00005344-199802000-00007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
36 Ardizzone G, Arrigo A, Schellino MM, Stratta C, Valzan S, Skurzak S, Andruetto P, Panio A, Ballaris MA, Lavezzo B. Neurological complications of liver cirrhosis and orthotopic liver transplant. Transplant Proc. 2006;38:789-792. [PMID: 16647471 DOI: 10.1016/j.transproceed.2006.01.039] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
37 Mueller AR, Platz KP, Schirmeier A, Nüssler NC, Seehofer D, Schmitz V, Nüssler AK, Radke C, Neuhaus P. L-arginine application improves graft morphology and mucosal barrier function after small bowel transplantation. Transplant Proc. 2000;32:1275-1277. [PMID: 10995944 DOI: 10.1016/S0041-1345(00)01222-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
38 Sevmis S, Karakayali H, Emiroglu R, Akkoc H, Haberal M. Tacrolimus-Related Seizure in the Early Postoperative Period After Liver Transplantation. Transplantation Proceedings 2007;39:1211-3. [DOI: 10.1016/j.transproceed.2007.02.049] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
39 Lauzurica R, Loscos J, Diaz-couchod P, Bayes B, de la Camara J. Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation: . Transplantation 2002;73:1006-7. [DOI: 10.1097/00007890-200203270-00033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Geller DA, Chia SH, Takahashi Y, Yagnik GP, Tsoulfas G, Murase N. Protective Role of the L-Arginine-Nitric Oxide Synthase Pathway on Preservation Injury after Rat Liver Transplantation. JPEN J Parenter Enteral Nutr 2016;25:142-7. [DOI: 10.1177/0148607101025003142] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
41 Senzolo M, Ferronato C, Burra P. Neurologic complications after solid organ transplantation. Transpl Int. 2009;22:269-278. [PMID: 19076332 DOI: 10.1111/j.1432-2277.2008.00780.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 71] [Article Influence: 9.0] [Reference Citation Analysis]
42 Bertz H, Laubenberger J, Steinfurth G, Finke J. SINUS VENOUS THROMBOSIS: An Unusual Cause for Neurologic Symptoms after Bone Marrow Transplantation under Immunosuppression. Transplantation 1998;66:241-4. [DOI: 10.1097/00007890-199807270-00018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
43 McDiarmid SV. The use of tacrolimus in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1998;26:90-102. [PMID: 9443127 DOI: 10.1097/00005176-199801000-00016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
44 Sathyan S, Baskharoun R, Perlman AS. Prevention of recurrent episodes of rhabdomyolysis with tacrolimus in a transplant recipient with myopathy. Am J Ther 2014;21:e171-4. [PMID: 23429166 DOI: 10.1097/MJT.0b013e318274df46] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Verbeek TA, Stine JG, Saner FH, Bezinover D. Osmotic demyelination syndrome: are patients with end-stage liver disease a special risk group? Minerva Anestesiol 2020;86. [DOI: 10.23736/s0375-9393.20.14120-8] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Quirós-tejeira RE, Chang I, Bristow LJ, Karpen SJ, Goss JA. Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient. Pediatric Transplantation 2005;9:792-6. [DOI: 10.1111/j.1399-3046.2005.00368.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
47 Bronster DJ, Chodoff L, Yonover P, Sheiner PA. CYCLOSPORINE LEVELS IN CEREBROSPINAL FLUID AFTER LIVER TRANSPLANTATION1: . Transplantation 1999;68:1410-3. [DOI: 10.1097/00007890-199911150-00030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
48 Ott R, Bussenius-kammerer M, Reck T, Koch CA, Kissler H, Hohenberger W, Muller V. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients. Transplant Int 2004;17:39-43. [DOI: 10.1111/j.1432-2277.2004.tb00381.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Ramanathan M, Uppalapu S, Patel NM. Hiding in Plain Sight: A Case of Ornithine Transcarbamylase Deficiency Unmasked Post-Liver Transplantation. Am J Transplant 2017;17:1405-8. [DOI: 10.1111/ajt.14174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
50 Henry ML. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles. Clin Transplant. 1999;13:209-220. [PMID: 10383101 DOI: 10.1034/j.1399-0012.1999.130301.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
51 Price DC. Radioisotopic evaluation of the thyroid and the parathyroids. Radiol Clin North Am. 1993;31:991-1015. [PMID: 8362060 DOI: 10.1002/14651858.cd011639.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
52 Yanik G, Levine JE, Ratanatharathorn V, Dunn R, Ferrara J, Hutchinson RJ. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 2000;26:161-7. [PMID: 10918426 DOI: 10.1038/sj.bmt.1702472] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
53 Bell A, Roberts HC, Chappell LH. The antiparasite effects of cyclosporin A: possible drug targets and clinical applications. Gen Pharmacol 1996;27:963-71. [PMID: 8909976 DOI: 10.1016/0306-3623(95)02148-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
54 Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol. 2009;63:761-767. [PMID: 19034447 DOI: 10.1007/s00280-008-0876-6] [Cited by in Crossref: 157] [Cited by in F6Publishing: 101] [Article Influence: 12.1] [Reference Citation Analysis]
55 Brunet M, Pou L, Torra M, López R, Rodamilans M, Corbella J. Comparative Analysis of Tacrolimus (FK506) in Whole Blood Liver Transplant Recipients by PRO-TRAC Enzyme-Linked Immunosorbent Assay and Microparticle Enzyme Immunoassay IMX Methods: . Therapeutic Drug Monitoring 1996;18:706-9. [DOI: 10.1097/00007691-199612000-00013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
56 Gruessner RW, Burke GW, Stratta R, Sollinger H, Benedetti E, Marsh C, Stock P, Boudreaux JP, Martin M, Drangstveit MB, Sutherland DE, Gruessner A. A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1: . Transplantation 1996;61:261-73. [DOI: 10.1097/00007890-199601270-00018] [Cited by in Crossref: 112] [Cited by in F6Publishing: 81] [Article Influence: 4.5] [Reference Citation Analysis]
57 Pratschke J, Neuhaus R, Tullius S, Jonas S, Bechstein W, Neuhaus P. Treatment of Cyclosporine-Related Adverse Effects by Conversion to Tacrolimus After Liver Transplantation: Long-Term Results. Transplantation Proceedings 1998;30:1419-21. [DOI: 10.1016/s0041-1345(98)00298-x] [Cited by in Crossref: 13] [Article Influence: 0.6] [Reference Citation Analysis]
58 Hansen T, D'alessandro A, Southard J. Long-term cold ischemia reduces nitric oxide metabolism in reperfused rabbit kidneys. Transplantation Proceedings 1997;29:3417-9. [DOI: 10.1016/s0041-1345(97)00961-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Trull AK. Therapeutic monitoring of tacrolimus. Ann Clin Biochem 1998;35 ( Pt 2):167-80. [PMID: 9547889 DOI: 10.1177/000456329803500201] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
60 Roy First M. An update on new immunosuppressive drugs undergoing preclinical and clinical trials: Potential applications in organ transplantation. American Journal of Kidney Diseases 1997;29:303-17. [DOI: 10.1016/s0272-6386(97)90046-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
61 Spolidorio L, Spolidorio D, Massucato E, Neppelenbroek K, Campanha N, Sanches M. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. Oral Diseases 2006;12:309-14. [DOI: 10.1111/j.1601-0825.2005.01200.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
62 Cronin DC, Faust TW, Brady L, Conjeevaram H, Jain S, Gupta P, Millis JM. MODERN IMMUNOSUPPRESSION. Clinics in Liver Disease 2000;4:619-55. [DOI: 10.1016/s1089-3261(05)70130-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
63 Rifaie N, Koeppen S, Treckmann JW, Paul A, Saner FH. New-Onset Parkinson Syndrome After Liver Transplantation. Transplantation 2012;94:e56-7. [DOI: 10.1097/tp.0b013e31826b85c9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
64 Cain MS, Burton GV, Holcombe RF. Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids. Am J Med Sci 1998;315:202-7. [PMID: 9519935 DOI: 10.1097/00000441-199803000-00011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
65 Cruz RJ, DiMartini A, Akhavanheidari M, Iacovoni N, Boardman JF, Donaldson J, Humar A, Bartynski WS. Posterior reversible encephalopathy syndrome in liver transplant patients: clinical presentation, risk factors and initial management. Am J Transplant. 2012;12:2228-2236. [PMID: 22494636 DOI: 10.1111/j.1600-6143.2012.04048.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
66 Torocsik H, Curless R, Post J, Tzakis A, Pearse L. FK506-induced leukoencephalopathy in children with organ transplants. Neurology 1999;52:1497-1497. [DOI: 10.1212/wnl.52.7.1497] [Cited by in Crossref: 47] [Cited by in F6Publishing: 1] [Article Influence: 2.1] [Reference Citation Analysis]
67 Saner FH, Sotiropoulos GC, Gu Y, Paul A, Radtke A, Gensicke J, Kavuk I, Malagó M, Broelsch CE. Severe neurological events following liver transplantation. Arch Med Res. 2007;38:75-79. [PMID: 17174727 DOI: 10.1016/j.arcmed.2006.07.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
68 Munoz SJ, Rothstein KD, Reich D, Manzarbeitia C. Long-term care of the liver transplant recipient. Clin Liver Dis 2000;4:691-710. [PMID: 11232168 DOI: 10.1016/s1089-3261(05)70133-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Papapetropoulos S, Tzakis A, Sengun C, Reddy C, Boukas K, Zitser J, Singer C. Case of pediatric acquired chronic hepatocerebral degeneration. Pediatr Neurol 2008;38:67-70. [PMID: 18054700 DOI: 10.1016/j.pediatrneurol.2007.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
70 Zini R, Simon N, Morin C, Thiault L, Tillement JP. Tacrolimus decreases in vitro oxidative phosphorylation of mitochondria from rat forebrain. Life Sci 1998;63:357-68. [PMID: 9714423 DOI: 10.1016/s0024-3205(98)00284-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
71 Ide K, Ohdan H, Tahara H, Ishiyama K, Shishida M, Irei T, Ohira M, Tashiro H, Itamoto T, Asahara T. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients. Transpl Int 2007;20:632-5. [PMID: 17442068 DOI: 10.1111/j.1432-2277.2007.00487.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
72 Pratschke J, Neuhaus R, Tullius SG, Haller GW, Jonas S, Steinmueller T, Bechstein WO, Neuhaus P. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. Transplantation. 1997;64:938-940. [PMID: 9326428 DOI: 10.1097/00007890-199709270-00029] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
73 Yoon JS, Kim YR, Choi JW, Ko JS, Gwak MS, Kim GS. Risk factors of postoperative delirium following liver transplantation. Korean J Anesthesiol 2009;57:584. [DOI: 10.4097/kjae.2009.57.5.584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Lee P, Tsai Y, Hung C, Lin Y, Lei H, Chuang J, Hsu K. Induction of Antinociception and Increased Met-Enkephalin Plasma Levels by Cyclosporine and Morphine in Rats: Implications of the Combined Use of Cyclosporine and Morphine and Acute Posttransplant Neuropsychosis. Journal of Surgical Research 2002;106:1-6. [DOI: 10.1006/jsre.2002.6392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
75 Ahrens CL, Manno EM. Neurotoxicity of commonly used hepatic drugs. Handb Clin Neurol 2014;120:675-82. [PMID: 24365346 DOI: 10.1016/B978-0-7020-4087-0.00046-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
76 Bilodeau M, Hassoun Z, Brunet D. Demyelinating Sensorimotor Polyneuropathy Associated With the Use of Sirolimus: A Case Report. Transplantation Proceedings 2008;40:1545-7. [DOI: 10.1016/j.transproceed.2008.03.094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
77 Platz KP, Mueller AR, Heckert C, Häusler M, Guckelberger O, Lobeck H, Neuhaus P. Nitric oxide production after syngeneic and allogeneic small bowel transplantation. Transplant Proc. 1998;30:2662-2664. [PMID: 9745538 DOI: 10.1016/S0041-1345(98)00779-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
78 Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 2008;23:2531-6. [PMID: 18258739 DOI: 10.1093/ndt/gfn013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
79 Scheel A, Blaschke S, Schettler V, Mayer C, Müller G, Bittermann H, Grunewald R. Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports. Transplantation Proceedings 2001;33:3693-4. [DOI: 10.1016/s0041-1345(01)02506-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Thyagarajan GK, Cobanoglu A, Johnston W. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. Ann Thorac Surg 1997;64:1461-4. [PMID: 9386723 DOI: 10.1016/S0003-4975(97)00939-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
81 Forgacs B, Merhav HJ, Lappin J, Mieles L. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 2005;37:1912-4. [PMID: 15919502 DOI: 10.1016/j.transproceed.2005.02.101] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
82 Lué A, Martinez E, Navarro M, Laredo V, Lorente S, Jose Araiz J, Agustin Garcia-gil F, Serrano MT. Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation. Transplantation 2019;103:e211-5. [DOI: 10.1097/tp.0000000000002750] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
83 Plochl W, Kozek-langenecker S, Spiss C, Plochl E, Pokorny H, Zacherl J, Muhlbacher F, Stockler-ipsiroglu S, Wermuth B. Multiorgan donation from a donor with unrecognized ornithine transcarbamylase deficiency. Transplant Int 2001;14:196-201. [DOI: 10.1111/j.1432-2277.2001.tb00041.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
84 Wszolek Z, Steg R. Seizures after orthotopic liver transplantation. Seizure 1997;6:31-9. [DOI: 10.1016/s1059-1311(97)80050-7] [Cited by in Crossref: 29] [Article Influence: 1.2] [Reference Citation Analysis]
85 Kakefuda T, Enosawa S, Li X, Tamura A, Funeshima N, Kanashiro M, Amemiya H, Kitajima M, Suzuki S. Nitrosyl hemoglobin detected by near-infrared spectroscopy in rat liver allografts. Transplant Int 1999;12:307-15. [DOI: 10.1111/j.1432-2277.1999.tb00615.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Jain AB, Fung JJ. Cyclosporin and Tacrolimus in Clinical Transplantation: A Comparative Review. Clin Immunother 1996;5:351-73. [DOI: 10.1007/bf03259333] [Cited by in Crossref: 17] [Article Influence: 1.9] [Reference Citation Analysis]
87 Assmann T, Homey B, Ruzicka T. Applications of tacrolimus for the treatment of skin disorders. Immunopharmacology 2000;47:203-13. [DOI: 10.1016/s0162-3109(00)00187-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
88 Jain A, Brody D, Hamad I, Rishi N, Kanal E, Fung J. Conversion to neoral for neurotoxicity after primary adult liver transplantation under tacrolimus. Transplantation 2000;69:172-6. [PMID: 10653398 DOI: 10.1097/00007890-200001150-00029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
89 Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Shishido S, Asanuma H, Nishimura G, Hiramoto R, Honda M. Posterior Reversible Encephalopathy Syndrome in Children: Its High Prevalence and More Extensive Imaging Findings. American Journal of Kidney Diseases 2006;48:231-8. [DOI: 10.1053/j.ajkd.2006.04.076] [Cited by in Crossref: 70] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
90 Tombazzi CR, Waters B, Shokouh-amiri MH, Vera SR, Riely CA. Neuropsychiatric Complications After Liver Transplantation: Role of Immunosuppression and Hepatitis C. Dig Dis Sci 2006;51:1079-81. [DOI: 10.1007/s10620-006-8012-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
91 Guérette B, Vilquin JT, Gingras M, Gravel C, Wood KJ, Tremblay JP. Prevention of Immune Reactions Triggered by First-Generation Adenoviral Vectors by Monoclonal Antibodies and CTLA4Ig. Human Gene Therapy 1996;7:1455-63. [DOI: 10.1089/hum.1996.7.12-1455] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
92 Dumont FJ, Koprak S, Staruch MJ, Talento A, Koo G, Dasilva C, Sinclair PJ, Wong F, Woods J, Barker J, Pivnichny J, Singer I, Sigal NH, Williamson AR, Parsons WH, Wyvratt M. A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH REDUCED TOXICITY: . Transplantation 1998;65:18-26. [DOI: 10.1097/00007890-199801150-00005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
93 Kilinç M, Benli S, Can U, Yilmaz A, Karakayali H, Colak T, Tarhan C, Ozdemir BH. FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report. Transplant Proc 2002;34:1182-4. [PMID: 12072309 DOI: 10.1016/s0041-1345(02)02802-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
94 Kizilisik AT, Shokouh-Amiri MH, Tombazzi CR, Desmukh S, Grewal HP, Vera SR, Gaber AO. Psychiatric complications after liver transplantation. Transplant Proc. 2001;33:3697. [PMID: 11750575 DOI: 10.1016/s0041-1345(01)02508-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
95 Kriss M, Sotil EU, Abecassis M, Welti M, Levitsky J. Mycophenolate mofetil monotherapy in liver transplant recipients. Clin Transplant. 2011;25:E639-E646. [PMID: 22007615 DOI: 10.1111/j.1399-0012.2011.01512.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
96 Gold BG. FK506 and the role of immunophilins in nerve regeneration. Mol Neurobiol 1997;15:285-306. [DOI: 10.1007/bf02740664] [Cited by in Crossref: 135] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]